Ginkgo biloba leaf extract suppresses intestinal human breast cancer resistance protein expression in mice: Correlation with gut microbiota - 17/06/21
pages | 12 |
Iconographies | 8 |
Vidéos | 0 |
Autres | 0 |
Abstract |
In this study, we investigated the effects of treatment with Gingko biloba leaf extract (GLE) on intestinal transporter expression and gut microbiota composition in mice and the correlation between intestinal transporter expression and gut microbiota composition in mice. When GLE was orally administered to mice, intestinal BCRP expression was significantly suppressed. Pharmacokinetic studies showed that the maximum plasma concentration and area under the curve values of sulfasalazine were increased more than twice by treatment with GLE compared with those in the control group. GLE treatment significantly decreased the populations of Proteobacteria and Deferribacteres at the phylum level. Correlation analysis showed that BCRP expression was positively or negatively correlated with the composition of gut bacteria. In Caco-2 cells, GLE treatment did not affect BCRP expression, but treatment with the lysates of GLE-treated mouse feces significantly suppressed BCRP expression. These findings demonstrate that the suppression of intestinal BCRP expression following GLE treatment may occur through modulation of the gut microbiota composition. Thus, the present study suggests that modulation of gut microbiota composition may cause drug transporter-mediated herb–drug interactions.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Modulation of gut microbiota composition by Ginkgo biloba leaf extracts treatment may cause drug transporter-mediated herb–drug interactions.
Highlights |
• | Gingko biloba leaf extract suppressed intestinal BCRP expression. |
• | Gingko biloba leaf extract modulated the gut microbiota composition. |
• | Gut bacteria composition was correlated with intestinal BCRP expression. |
• | Modulation of gut microbiota may affect drug transporter expression. |
Keywords : Gut microbiota, Drug transporter, BCRP, Ginkgo biloba leaf extract, Herb-drug interaction
Plan
Vol 140
Article 111712- août 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?